Content about Abbott

ABBOTT PARK, Ill. — Patients with a form of arthritis that affects young adults taking a drug made by Abbott experienced improvements in their condition after a year of treatment, according to late-stage clinical trial results.

Abbott announced Monday the first long-term patient-reported health outcomes data for the phase-3 "ABILITY-1" trial of Humira (adalimumab) in patients with nonradiographic axial spondyloarthritis, or nr-axSpA. Results of the trial were presented at the American College of Rheumatology's annual scientific meeting in Washington.

News broke last month that officials in the South American nation of Uruguay were planning to possibly legalize marijuana. Meanwhile, activists in Colorado have sought to legalize the drug in that state, while Chicago’s city council decriminalized possession of small amounts of marijuana and reduced the penalty to a ticket.


ABBOTT PARK, Ill. — Abbott on Tuesday announced the launch of Ensure Clear, a nutrition beverage available in peach and blueberry pomegranate flavors that offers three times more protein than juice, according to the company, and 21 vitamins and minerals to help adults looking to fill dietary gaps.

ABBOTT PARK, Ill. — Abbott recently launched Perfectly Simple by ZonePerfect, a line extension that is gluten-free and features fewer ingredients in each bar (between six and 10 ingredients).

Shipping in April, Perfectly Simple by ZonePerfect is available in three flavors: peanut crunch, cranberry almond and toasted coconut. The nutrition bars contain 10 g of protein, with no preservatives or added coloring. Each bar contains between 170 and 200 calories.

PARSIPPANY, N.J. — Watson Pharmaceuticals is challenging the patent protection on a drug made by Abbott for treating cholesterol, the company said.

Watson, through a subsidiary, filed with the Food and Drug Administration for approval of niacin extended-release tablets in the 500-mg and 1,000-mg strengths. The drug is a generic version of Abbott's Niaspan.

ALAMEDA, Calif. — A blood-glucose monitoring system created by Abbott has received clearance from the Food and Drug Administration.

ABBOTT PARK, Ill. — Abbott has introduced a new BPA-free baby bottle, which includes several innovative features that are designed to improve the bottle-feeding experience.

The Similac SimplySmart bottle is designed for easy reading, cleaning and filling and includes the following features: an EasyMix mixing device designed to reduce bubbles and clumps; a Similac On-The-Go powder cap that can enough formula for an 8-oz. bottle; an Intellivent venting system to minimize a baby's air intake; a SmartClose that prevents leaks and a naturally shaped nipple.

The market for meal replacement ready-to-drink shakes is expanding beyond the need for a shake-shake-sensible-meal diet plan, or the need for a protein booster, with a number of niche marketing opportunities.


ABBOTT PARK, Ill. — A large number of patients with a serious form of arthritis experienced improvement in their condition after taking a drug made by Abbott Labs for three months, according to results of a late-stage clinical trial announced Monday.

MECHANICSBURG, Pa. — Abbott last week officially announced the launch of Glucerna Hunger Smart nutrition shakes, pictured here at a central Pennsylvania Wegmans, that specifically targets patients living with diabetes. It's a testament to the opportunity in serving up products that will appeal to as many as one-third of the population, which happens to be the number of Americans who will be diagnosed with diabetes if current trends continue.

ABBOTT PARK, Ill. — Abbott has introduced a new line of nutrition shakes and bars for people with diabetes.

Glucerna Hunger Smart includes two flavors of nutrition shakes, including homemade vanilla and rich chocolate, in addition to two flavors of nutrition bars, including chocolate peanut butter crisp and chocolate chip crisp.